tetano
Editor, Senior Moderator
J Rheumatol
. 2022 Mar 1;jrheum.211313.
doi: 10.3899/jrheum.211313. Online ahead of print.
Immunogenicity of COVID-19 vaccination in patients with ankylosing spondylitis: a monocentric prospective belgian cohort study
Tracy Vandergraesen[SUP] 1 [/SUP], Leila Mekkaoui[SUP] 1 [/SUP], Hafid Dahma[SUP] 1 [/SUP], Muhammad Soyfoo[SUP] 1 [/SUP], Laure Tant[SUP] 1 [/SUP]
Affiliations
Abstract
Vaccination is cardinal in restraining the pandemic of COVID-19 caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The increased risk of severe COVID-19 infection in patients with inflammatory rheumatic diseases (IRD) makes vaccination particularly relevant in this population (1).
. 2022 Mar 1;jrheum.211313.
doi: 10.3899/jrheum.211313. Online ahead of print.
Immunogenicity of COVID-19 vaccination in patients with ankylosing spondylitis: a monocentric prospective belgian cohort study
Tracy Vandergraesen[SUP] 1 [/SUP], Leila Mekkaoui[SUP] 1 [/SUP], Hafid Dahma[SUP] 1 [/SUP], Muhammad Soyfoo[SUP] 1 [/SUP], Laure Tant[SUP] 1 [/SUP]
Affiliations
- PMID: 35232807
- DOI: 10.3899/jrheum.211313
Abstract
Vaccination is cardinal in restraining the pandemic of COVID-19 caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The increased risk of severe COVID-19 infection in patients with inflammatory rheumatic diseases (IRD) makes vaccination particularly relevant in this population (1).